A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

This study is not yet open for participant recruitment.

Study NCT00006154 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: August 7, 2000 Last Updated: April 23, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given